This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of accessory sinuses, including Hilmo
C3_ACCESSORY_SINUS_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
168 |
4. Check minimum number of eventsNone |
168 |
5. Include endpointsNone |
168 |
6. Filter based on genotype QC (FinnGen only) |
162 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of accessory sinuses, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasal cavity and sinuses, including Hilmo
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 162 | 61 | 101 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | 63.51 | 60.92 | 65.07 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 168
- Matched controls
- 1680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
64.9
58
*
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
58.9
53
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.5
40.7
61
95
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
39.1
36
*
H02AB02
ATC
dexamethasone; systemic
71.5
38.6
43
8
UDH02
NOMESCO Finland
Rhinopharyngoscopy
10.9
37.0
46
56
XX3DW
NOMESCO Finland
Time consuming IT work
14.5
35.4
35
30
WF002
NOMESCO Finland
Radical radiotherapy
211.5
34.1
34
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
32.3
30
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
30.1
28
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
30.1
28
*
WZC00
NOMESCO Finland
Treatment plan or consultation
5.6
27.2
80
235
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
305.4
26.5
26
*
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
+∞
25.7
24
*
N02AA05
ATC
oxycodone; systemic
6.0
25.5
59
139
A04AA02
ATC
granisetron; systemic, transdermal
291.6
25.4
25
*
C31.1
ICD-10 Finland
Malignant neoplasm: Ethmoidal sinus
+∞
23.5
22
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
58.3
21.8
25
5
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
+∞
21.3
20
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
21.3
20
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.2
19
*
8070/3-C31.0
ICD-O-3
Squamous cell carcinoma, NOS, of maxillary sinus
+∞
20.2
19
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
20.2
19
*
UDM02
NOMESCO Finland
Sinoscopy
23.7
19.9
28
14
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
39.6
19.5
24
7
A04AA01
ATC
ondansetron; systemic, rectal
26.4
18.4
25
11
Z51.5
ICD-10 Finland
Palliative care
15.7
17.8
29
22
JN4BD
NOMESCO Finland
Extensive body CT
8.2
17.5
25
35
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
8.2
17.5
25
35
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
17.0
16
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
17.0
16
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
34.0
16.6
21
7
JDB10
NOMESCO Finland
Percutaneous gastrostomy
66.7
16.1
18
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
15.9
15
*
A07AA02
ATC
nystatin; oral
7.6
15.8
24
36
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
14.8
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.8
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.8
14
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
40.0
14.8
18
5
R04.0
ICD-10 Finland
Epistaxis
5.3
14.5
33
74
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
58.5
14.1
16
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
18.2
13.9
21
13
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
81.6
13.8
15
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
13.7
13
*
L03AA13
ATC
pegfilgrastim; parenteral
151.8
13.7
14
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
43.9
13.4
16
*
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
+∞
12.7
12
*
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
140.0
12.6
13
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
17.7
12.5
19
12
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.3
12.0
35
96
WX402
NOMESCO Finland
General anaesthesia
4.1
11.8
38
112
ZX090
NOMESCO Finland
Other technic of radiotherapy
70.0
11.8
13
*
EEB10
NOMESCO Finland
Maxillectomy
+∞
11.6
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.6
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.6
11
*
L03AA02
ATC
filgrastim; parenteral
128.4
11.6
12
*
EEB00
NOMESCO Finland
Partial excision of maxilla
128.4
11.6
12
*
DPA30
NOMESCO Finland
Sphenotomy
37.9
11.5
14
*
SBB10
NOMESCO Finland
Dental impressions
5.9
11.4
22
42
EBB10
NOMESCO Finland
Insertion of dental implant
46.7
11.1
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
64.2
10.8
12
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
64.2
10.8
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
117.0
10.5
11
*
WZC30
NOMESCO Finland
Teaching
4.1
10.5
33
95
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
10.5
10
*
GBB00
NOMESCO Finland
Tracheostomy
20.4
10.5
15
8
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
10.0
9.8
19
21
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
12.5
9.8
17
15
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.3
9.7
27
71
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
9.5
9
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.5
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.5
9
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
9.5
9
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
+∞
9.5
9
*
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
+∞
9.5
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.5
9
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.0
9.1
20
28
ZXC95
NOMESCO Finland
Use of surgical navigator
25.7
9.0
12
5
WW500
NOMESCO Finland
Blood transfusion
11.7
9.0
16
15
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.7
9.0
16
15
SAA03
NOMESCO Finland
Extended examination of mouth
2.7
9.0
72
363
EBB15
NOMESCO Finland
Insertion of dental implant abutment
52.8
8.8
10
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
52.8
8.8
10
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
21.4
8.6
12
6
WF049
NOMESCO Finland
Radiotherapy of metastasis
94.6
8.5
9
*
ZZC00
NOMESCO Finland
Graft of fascia
94.6
8.5
9
*
SPF20
NOMESCO Finland
Temporary relining of dentures
94.6
8.5
9
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
94.6
8.5
9
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
8.4
8
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
8.4
8
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
8.4
8
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
7.9
48
207
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
7.9
41
162
ZX120
NOMESCO Finland
Intravenous
4.7
7.9
19
44
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
8.7
7.8
16
20
DHB40
NOMESCO Finland
Conchotomy
47.2
7.8
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
7.8
30
99
DPB00
NOMESCO Finland
Partial excision of frontal sinus
83.6
7.5
8
*
L02AE02
ATC
leuprorelin; implant, parenteral
83.6
7.5
8
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
11.6
7.4
13
12
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
7.3
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
7.3
7
*
DKW40
NOMESCO Finland
Ligature of artery of internal nose
+∞
7.3
7
*
1600A
ICD-9 Finland
Malignant neoplasm of nasal cavities, middle ear and accessory sinuses, Nasal cavities
+∞
7.3
7
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
ZZR00
NOMESCO Finland
Flap of skin
+∞
7.3
7
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
7.3
7
*
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
C31.3
ICD-10 Finland
Malignant neoplasm: Sphenoidal sinus
+∞
7.3
7
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.1
7.3
17
26
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.4
7.3
19
47
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
21.1
7.2
10
5
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
14.6
7.0
11
8
ZXE00
NOMESCO Finland
One hour or less
2.4
7.0
70
384
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
11.6
6.9
12
11
R4190
NOMESCO Finland
Nutritional therapy
11.6
6.9
12
11
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
41.8
6.8
8
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
72.5
6.5
7
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.2
6.4
18
47
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
18.9
6.3
9
5
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
6.3
6
*
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
+∞
6.3
6
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
6.3
6
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
6.3
6
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
6.3
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
6.0
6.2
16
29
SCA02
NOMESCO Finland
Preventive oral health care
3.6
6.1
21
64
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
31
79
4.59
11.63
2.3
2.0
0.24
0.21
g/l
1.28
31
63
53
227
2.95
8.98
3.1
2.0
—
—
—
0
0
86
474
2.67
8.95
5.9
3.3
32.44
35.61
g/l
4.10
78
422
94
564
2.51
7.90
10.4
5.4
1.21
1.21
mmol/l
0.36
78
488
70
368
2.55
7.79
6.2
2.1
2.36
2.34
mmol/l
0.35
65
300
81
474
2.37
6.95
3.7
2.3
—
—
—
0
0
12
12
10.66
6.65
1.2
1.1
—
—
—
0
0
33
130
2.91
6.34
8.0
6.5
0.83
1.58
mmol/l
0.35
26
105
83
506
2.27
6.30
8.6
5.0
1.20
1.21
mmol/l
0.61
75
448
94
631
2.11
5.32
19.1
6.0
3.87
4.16
e9/l
0.63
86
554
7
5
14.52
4.61
4.1
7.2
—
—
—
0
0
12
23
5.53
4.55
1.6
1.2
—
—
—
0
0
11
19
6.11
4.52
1.9
1.3
—
—
—
0
0
95
681
1.91
4.07
7.3
4.1
6.97
6.84
mmol/l
0.27
89
628
10
21
4.99
3.61
2.2
2.0
85.40
86.29
%
—
10
21
96
1191
0.55
3.51
4.5
4.7
4.69
4.52
mmol/l
0.76
88
1090
13
37
3.72
3.49
1.6
4.1
—
—
—
0
0
60
388
1.85
3.41
2.6
2.8
—
—
—
0
0
6
7
8.83
3.29
1.5
1.3
—
—
—
0
0
9
19
4.94
3.29
5.9
2.3
28.78
9.75
u/ml
—
9
12
96
1183
0.56
3.28
4.6
4.6
1.42
1.43
mmol/l
0.12
88
1078
96
1183
0.56
3.28
5.5
4.6
6.02
6.06
mmol/l
0.10
85
1060
100
1216
0.56
3.20
4.9
5.2
2.75
2.65
mmol/l
0.39
91
1107
82
594
1.74
3.12
7.8
16.1
1.18
1.40
inr
1.48
26
167
18
76
2.53
3.01
1.2
1.7
—
—
—
0
0
5
5
10.25
2.99
1.8
1.0
—
—
—
0
0
93
1137
0.59
2.77
4.4
4.2
1.34
1.28
mmol/l
0.36
82
1030
5
6
8.54
2.76
1.8
1.8
2.20
3.45
mg/l
—
5
6
7
15
4.82
2.62
1.7
1.1
—
—
—
0
0
23
117
2.12
2.55
5.1
3.2
—
—
—
0
0
6
12
5.14
2.42
1.8
1.1
—
—
—
0
0
6
12
5.14
2.42
3.3
1.2
—
—
—
0
0
7
17
4.25
2.38
2.1
2.4
200.71
196.24
%
—
7
17
7
18
4.01
2.27
1.4
1.1
—
—
—
0
0
5
9
5.69
2.23
2.2
1.2
—
—
—
0
0
45
299
1.69
2.22
2.6
2.7
0.30
0.44
e6/l
0.32
34
218
95
1132
0.63
2.22
6.4
6.3
40.67
40.90
mmol/mol
0.08
85
1037
6
14
4.40
2.17
1.0
1.0
—
—
—
0
0
9
31
3.01
2.10
4.8
1.2
64.44
30.99
mg/l
—
9
25
5
10
5.11
2.08
1.4
1.1
—
—
—
0
0
5
10
5.11
2.08
1.4
1.1
—
—
—
0
0
5
10
5.11
2.08
1.4
1.1
—
—
—
0
0
5
10
5.11
2.08
1.4
1.1
—
—
—
0
0
5
10
5.11
2.08
1.4
1.1
—
—
—
0
0
5
10
5.11
2.08
1.4
1.1
—
—
—
0
0
7
20
3.60
2.08
1.3
1.3
—
—
—
0
0
6
15
4.11
2.06
1.7
1.3
—
—
—
0
0
6
17
3.62
1.85
3.5
1.2
—
—
—
0
0
6
18
3.42
1.76
3.3
1.2
—
—
—
0
0
11
48
2.38
1.74
1.1
1.0
—
—
—
0
0
89
725
1.48
1.74
3.7
4.3
67.60
325.42
e6/l
—
5
12
8
31
2.66
1.68
5.3
1.2
29.18
45.99
mg/l
—
8
25
7
25
2.88
1.67
1.6
1.2
—
—
—
0
0
8
32
2.57
1.62
1.6
1.3
4649.13
3847.96
e6/l
—
8
25
8
32
2.57
1.62
1.6
1.2
68.00
5.88
e6/l
—
8
25
29
191
1.63
1.47
2.7
1.6
—
—
—
0
0
35
242
1.56
1.46
2.9
3.9
158.44
202.23
ng/l
0.11
29
189
41
295
1.52
1.43
2.0
2.1
2.97
3.07
mg/l
0.10
34
247
22
136
1.71
1.41
2.5
1.7
—
—
—
0
0
22
136
1.71
1.41
2.5
1.7
—
—
—
0
0
5
17
3.00
1.37
4.4
3.2
64.00
61.76
%
—
5
17
30
421
0.65
1.32
6.3
3.8
7.58
7.31
mg/mmol
0.02
21
275
26
173
1.59
1.27
2.1
2.6
1.92
2.90
e6/l
0.36
17
92
12
66
1.88
1.12
1.3
1.3
106.26
569.60
u/ml
0.70
12
61
33
241
1.46
1.08
1.7
1.7
1.18
1.12
mg/l
0.07
27
179
13
75
1.79
1.06
2.0
1.4
—
—
—
0
0
15
91
1.71
1.04
3.4
2.0
67.95
67.49
g/l
0.11
15
83
57
462
1.35
1.03
2.3
2.1
77.07
76.76
nmol/l
0.03
52
411
123
1329
0.72
1.03
39.8
18.3
36.67
40.40
%
4.46
116
1219
57
464
1.35
1.00
2.1
2.5
189.96
120.37
ug/l
1.08
51
422
15
93
1.67
0.97
3.5
2.1
70.14
63.81
ml/min/173m2
—
7
32
7
37
1.93
0.95
2.3
1.3
—
—
—
0
0
99
1098
0.76
0.94
6.4
4.3
2.33
1.95
mu/l
1.02
88
978
11
64
1.77
0.88
2.4
1.7
—
—
—
0
0
6
30
2.04
0.88
2.0
2.2
—
—
—
0
0
24
322
0.70
0.83
1.3
1.7
1.25
1.39
mmol/l
0.38
17
268
0
27
0.00
0.78
0.0
1.2
—
0.88
—
0
21
11
171
0.62
0.77
13.8
6.8
—
—
—
0
0
7
39
1.83
0.73
5.0
1.2
12.61
9.97
g/l
—
7
34
7
39
1.83
0.73
5.0
1.2
35.49
38.25
g/l
—
7
34
46
549
0.78
0.72
4.8
3.7
1.68
2.07
ug/l
0.89
41
482
7
42
1.70
0.69
3.6
1.5
—
—
—
0
0
5
27
1.88
0.69
1.0
1.2
—
—
—
0
0
82
730
1.24
0.68
3.1
2.9
55.51
50.39
u/l
0.24
77
674
0
20
0.00
0.61
0.0
3.8
—
41.50
—
0
6
0
21
0.00
0.60
0.0
1.1
—
20.40
—
0
5
8
54
1.51
0.58
2.1
3.2
26.70
24.84
mmol/l
—
8
49
5
88
0.56
0.58
1.4
1.5
—
—
—
0
0
48
414
1.22
0.52
2.6
3.2
644.91
1680.25
ng/l
3.59
43
355
7
46
1.54
0.49
5.0
1.3
—
—
—
0
0
7
46
1.54
0.49
5.0
1.3
7.46
7.66
g/l
—
7
41
7
46
1.54
0.49
5.0
1.3
3.47
2.85
g/l
—
7
41
7
46
1.54
0.49
5.0
1.3
3.40
3.77
g/l
—
7
41
23
184
1.29
0.46
1.9
2.4
0.93
0.99
e6/l
0.04
12
103
24
292
0.79
0.44
2.9
2.6
0.67
0.76
ug/l
0.31
15
192
50
563
0.84
0.43
4.2
3.7
0.00
0.00
estimate
-0.00
13
90
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
124
1181
1.19
0.41
28.9
12.7
30.10
24.99
mg/l
0.91
113
882
59
652
0.85
0.41
2.9
2.5
—
—
—
0
0
5
35
1.44
0.39
1.6
1.3
—
—
—
0
0
13
98
1.35
0.39
4.7
2.5
4.48
4.73
kpa
0.23
13
90
50
555
0.86
0.36
4.1
3.7
0.00
0.00
estimate
-0.00
13
100
50
553
0.86
0.34
5.1
5.1
0.00
0.00
estimate
-0.00
12
91
29
249
1.20
0.33
1.6
1.8
977.28
1168.11
nmol/l
0.59
22
193
18
152
1.21
0.25
1.2
1.4
—
—
—
0
0
49
530
0.89
0.23
3.6
3.9
34.86
113.03
ng/l
0.67
36
395
39
427
0.89
0.23
5.8
3.6
23.38
23.90
%
0.07
17
195
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
39.38
—
0
6
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
123
1262
0.91
0.19
31.0
15.3
3.96
4.00
mmol/l
1.08
117
1205
41
442
0.90
0.18
4.3
3.8
—
—
—
0
0
8
100
0.79
0.14
1.8
1.7
—
—
—
0
0
109
1117
0.93
0.13
28.4
11.5
81.57
76.50
ml/min/173m2
1.82
98
883
90
873
1.07
0.12
5.6
3.6
14.11
14.95
pmol/l
2.38
82
790
10
85
1.19
0.12
2.0
2.8
4.56
1.52
mmol/l
—
5
57
32
300
1.08
0.11
1.8
1.6
15.67
20.62
nmol/l
1.21
27
260
7
63
1.12
0.08
2.6
2.2
0.80
1.09
%
—
7
63
11
123
0.89
0.08
1.2
1.3
—
—
—
0
0
10
89
1.13
0.07
2.2
2.8
5.07
4.90
kpa
—
10
84
101
1003
1.02
0.01
33.8
14.4
16.03
15.36
%
0.44
101
979
51
514
0.99
0.00
2.0
2.0
90.48
93.81
pmol/l
0.21
32
271
31
307
1.01
0.00
4.9
3.9
0.00
0.00
estimate
-0.00
13
87
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
2.15
—
0
7
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
13.94
—
0
5
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.8
—
19.29
—
0
8
0
6
0.00
-0.00
0.0
1.2
—
21.83
—
0
6
0
5
0.00
-0.00
0.0
1.8
—
26.52
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_ACCESSORY_SINUS_WIDE – Malignant neoplasm of accessory sinuses, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).